中国临床药理学杂志2016，Vol.32Issue(12)：1075-1077,3.DOI:10.13699/j.cnki.1001-6821.2016.12.006
神经节苷脂联合银杏达莫对颅脑损伤患者的临床研究
Clinical trial of ganglioside combined with ginkgo dipyridamolum in the treatment of craniocerebral injury
摘要
Abstract
Objective To evaluate the clinical effect of ganglioside com-bined with ginkgo dipyridamolum in the treatment of craniocerebral inju-ry.Methods Sixty-four traumatic brain injury patients were randomly divided into treatment group and control group , 32 cases in each group.Control group was intravenously dripped ganglioside 20 mL, two times a day.Treatment group was intravenously given the injection of ginkgo dipyridamolum 10 mL, once a day , on the basis of control group.All pa-tients were treated for 1 month.Clinical effect , activity of daily living ( ADL) score, the degree of neurological deficit and the incidence of ad-verse drug reactions were observed.Results After treatment , the clini-cal efficacy of treatment group was 96.87%, significantly higher than 78.13%in control group ( P<0.05 ).After treatment , the ADL scores of two groups were significantly higher than those before treatment ( P<0.05 ).The neurological deficit score in treatment group was statisti-cally lower than that before treatment and control group ( P <0.05 ).There were no adverse drug reactions in two groups during the treatment.Conclusion The clinical effect of ganglioside combined with ginkgo dipyridamolum in the treatment of craniocerebral injury was better than that of ganglioside , which can improve the ability of daily life and the quality of life of patients.关键词
神经节苷脂/银杏达莫/颅脑损伤Key words
ganglioside/ginkgo dipyidamolum/craniocerebral injury分类
医药卫生引用本文复制引用
王盛,王朝平,陈太董..神经节苷脂联合银杏达莫对颅脑损伤患者的临床研究[J].中国临床药理学杂志,2016,32(12):1075-1077,3.基金项目
海南省社会发展科技专项基金资助项目 （）
